Skip to main content

Animations

MJFF Publications

5071 - 5080 of 6324 Results
Title
Year
  • Year
  • 2018
  • 2018
  • 2023
  • 2018
  • 2018
  • 2025
  • 2025
  • 2021
  • 2022
  • 2021
  • Summary Details
    OPEN
    Title: Loss of kallikrein‐related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.201708184
    Citation Count: 47
  • Summary Details
    OPEN
    Title: A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.06.001
    Citation Count: 119
  • Summary Details
    OPEN
    Title: Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00476-2
    Citation Count: 14
  • Summary Details
    OPEN
    Title: The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2018.00064
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Atrophy in the Thalamus But Not Cerebellum Is Specific for C9orf72 FTD and ALS Patients – An Atlas-Based Volumetric MRI Study
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2018.00045
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Parkinson’s Disease Caregiving, Level of Care Burden, Caregiving-Related Strain, and Caregiver Health
    Journal Name: Healthcare
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/healthcare13131520
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Motor and nonmotor features of p.A53T alpha-synuclein PD vs idiopathic PD: longitudinal data from the PPMI study
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-024-12836-w
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28549
    Citation Count: 98
  • Summary Details
    OPEN
    Title: Palladium-Catalyzed α-Arylation of Cyclic β-Dicarbonyl Compounds for the Synthesis of CaV1.3 Inhibitors
    Journal Name: ACS Omega
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1021/acsomega.2c00889
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learning
    Journal Name: The Lancet Digital Health
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/s2589-7500(21)00101-1
    Citation Count: 62
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.